These data could suggest that MYC-driven lung metastasis might benefit from treatments that reinvigorate the immune system, for example with a drug combo that combines induction of cancer cell killing and immune checkpoint blockade such as the aforementioned combination of venetoclax, metformin and anti-PD-125. This evidence concerns the gene MYC and cancer.